News Headlines Article

Alzheimer’s: ‘Triple-action’ diabetes drug shows promise as treatment
Medical News Today

Scientists in the United Kingdom and China find that a new drug for type 2 diabetes may protect the brain from damage caused by Alzheimer’s disease, after testing it in mice.

In a new paper published in the journal Brain Research, the researchers explain how the “triple-action” drug resulted in a significant reversal of memory loss in mice that were genetically engineered to develop human-like Alzheimer’s disease.

The new drug “holds clear promise of being developed into a new treatment for chronic neurodegenerative disorders such as Alzheimer’s disease,” says study leader Christian Hölscher, a professor in the Faculty of Health and Medicine at Lancaster University in the U.K.

Alzheimer’s is a brain-wasting disease that accounts for 50–75 percent of cases of dementia, which is a condition wherein people gradually lose their ability to think, remember, make decisions, hold a conversation, and look after themselves.